These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9842263)

  • 1. [Standardization of the lethal dose 50% of Leptospira interrogans strains used in the control of the leptospirosis cuban vaccine for human use].
    Fajardo EM; Ortiz B; Chávez A; Gaínza N; Izquierdo L; Hernández Y; Labrador I; Alvarez E
    Rev Cubana Med Trop; 1998; 50(1):22-6. PubMed ID: 9842263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
    González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
    Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The reactogenicity and immunogenicity of the first Cuban vaccine against human leptospirosis].
    Martínez Sánchez R; Obregón Fuentes AM; Pérez Sierra A; Baly Gil A; Díaz González M; Baró Suárez M; Menéndez Capote R; Ruiz Pérez A; Sierra González G; López Chávez AU
    Rev Cubana Med Trop; 1998; 50(2):159-66. PubMed ID: 10349437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the vaccine potentiality of 2 strains from Leptospira interrogans serogroup Ballum].
    Rodríguez AG; Jiménez YR; Santiesteban NB; Abreu YV; Osenes JF; González MG
    Rev Cubana Med Trop; 2005; 57(1):63-4. PubMed ID: 17966485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of monoclonal antibody methodology as a tool for serotyping leptospira isolates in Cuba.
    Obregón AM; Fernández C; Rodríguez I; Rodríguez J
    Rev Cubana Med Trop; 2007; 59(1):68-70. PubMed ID: 23427423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira (L.) serogroup Icterohaemorrhagiae and L. serogroup Canicola in the United States.
    Walker A; Olsen R; Toth M; Srinivas G
    Biologicals; 2018 Nov; 56():13-18. PubMed ID: 30126631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microbiological characterization of candidate vaccine strains of Ballum serogroup Leptospira interrogans].
    Rodríguez AG; Jimenez YR; Santiesteban NB; Abreu YV; González MG
    Rev Cubana Med Trop; 2003; 55(3):146-52. PubMed ID: 15849918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of diafiltration in the lavage of cultures of Leptospira interrogans canicola canicola for the production of vaccine vax-SPIRAL].
    Enrique KF; Zamora JD; Gutiérrez RB; Torres FH; Airado JL; Hernández DR
    Rev Cubana Med Trop; 2005; 57(1):69-70. PubMed ID: 17966488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental immunization of hamsters with an EDTA extract of Leptospira interrogans, serovar icterohaemorrhagiae.
    de Queiroz-Leite LT; Resende M; Ramos-Vieira M das N; Cota-Koury M
    Rev Latinoam Microbiol; 1996; 38(1):39-43. PubMed ID: 8783904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response of antileptospira IgG antibodies in individuals immunized with vax-SPIRAL].
    Rodríguez I; Martínez R; Zamora Y; Rodríguez JE; Fernández C; Obregón AM
    Rev Cubana Med Trop; 2005; 57(1):32-7. PubMed ID: 17966473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The identification of Leptospira strains of different origins].
    Regalado Seguí JD; López Acosta C; Saltarén A; Atienzar E
    Rev Cubana Med Trop; 1992; 44(1):33-6. PubMed ID: 1344685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Solubilization of components of outer membrane of Leptospira interrogans serovar mozdok by sodium desoxycholate and triton X-100 and evaluation of their immunogenic capacity and homologous and heterologous protection induced in hamsters].
    Rivera YF; Navarro YP; Mazorra YA; Rodríguez AG; Padrón Mde L; Valdés Y
    Rev Cubana Med Trop; 2005; 57(1):53-4. PubMed ID: 17966480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The maintenance of challenge strains used in the potency test for canine leptospira vaccines.
    Reed NE; Varney WC; Goddard RD; Wyeth PJ
    Biologicals; 2000 Mar; 28(1):25-8. PubMed ID: 10799052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity among major endemic strains of Leptospira interrogans in China.
    He P; Sheng YY; Shi YZ; Jiang XG; Qin JH; Zhang ZM; Zhao GP; Guo XK
    BMC Genomics; 2007 Jul; 8():204. PubMed ID: 17603913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two different potency tests for leptospirosis vaccine vax-SPIRAL.
    Núñez JF; Fajardo EM; Pérez E; Ontivero I; Silva D; Muñoz P
    Rev Cubana Med Trop; 2005; 57(1):67-8. PubMed ID: 17966487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunising potency of Leptospira interrogans serotype canicola after heat inactivation at different temperatures.
    Painter GM; Ellinghausen HC
    J Med Microbiol; 1976 Nov; 9(4):487-92. PubMed ID: 1003455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of renal infection and urinary shedding in dogs by a Leptospira vaccination.
    Schreiber P; Martin V; Najbar W; Sanquer A; Gueguen S; Lebreux B
    Vet Microbiol; 2005 Jun; 108(1-2):113-8. PubMed ID: 15917139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.
    Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK
    BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a method to determine the minimum inhibitory concentration in reference strains from leptospiras].
    Obregón AM; Llanes R; Fernández C; Hernández I; Rodriguez J
    Rev Cubana Med Trop; 2005; 57(1):11-6. PubMed ID: 17966469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptospiral immunoglobulin-like proteins elicit protective immunity.
    Koizumi N; Watanabe H
    Vaccine; 2004 Mar; 22(11-12):1545-52. PubMed ID: 15063580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.